A singular focus on healthcare enables our Institutional Equities team to develop deeper knowledge which our clients leverage to execute their strategies and achieve their goals.
LEERINK’s sales & trading team offers superior execution capabilities rooted in our singular focus on healthcare and knowledge-led approach. More thorough knowledge improves our clients’ understanding of the unique complexity of successful healthcare investing, including science, regulatory pathways and reimbursement issues. Such informed healthcare investors are more likely to be valuable long-term shareholders, which is critical to continued innovation and breakthroughs in science and technology. Our healthcare-focused sales & trading services extend to:
- Equity Derivatives
- Convertible Bonds & Notes
MEDACorp, a strategic knowledge resource.
LEERINK’s Corporate Access creates exclusive opportunities for management teams and institutional investors in healthcare to build and strengthen relationships, offering market intelligence and strategic advisory to yield better investment decisions.
We collaborate with Equity Research, Sales & Trading and Investment Banking to drive connections with management teams and institutional investors through world-class events that highlight our deep healthcare knowledge and network. These exclusive interactions are facilitated through conferences, roadshows and other marquee events, and executed throughout the U.S., Canada and Europe.
We work directly with our institutional investors to provide targeted strategies that achieve their business and financial objections while delivering our corporate management teams a powerful client network to deepen existing relationships while generating new ones.
In 2017, we hosted approximately 3,000 company meetings with an overall attendance rate reaching 9,000 individuals.